CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

Buddyboy20

07/28/2025 6:52:03 PM

Two study locations? (1)

Mr3Putt

07/28/2025 6:40:22 PM

updates posted to CRC trial: (7)

sherlock57

07/28/2025 4:46:46 PM

"Since we are doing a clinical trial, (12)

sunray3

07/28/2025 12:02:02 PM

If so (not doubting you) then not (8)

Buddyboy20

07/28/2025 11:25:09 AM

I can almost guarantee that his (2)

sunray3

07/28/2025 11:18:19 AM

Thanks for the update on Dr C's (7)

Buddyboy20

07/28/2025 10:00:14 AM

It has been over one year that Dr Chan (22)

Mr3Putt

07/28/2025 9:48:14 AM

Your question is answered precisely (2)

SaltyMutt

07/28/2025 7:51:21 AM

Does this one fly soon? (1)

bbqbbq

07/27/2025 10:12:45 PM

Garry Nolan is a prominent immunologist (4)

My69z

07/27/2025 8:33:43 PM

Reason for S3's is being overlooked --- (5)

sean007

07/27/2025 6:59:58 PM

You can believe with Tanya at the (10)

USS JOHNSTON

07/27/2025 5:09:10 PM

Thanks, 3Putt, that discussion on (7)

ohm20

07/27/2025 5:03:55 PM

Upwithstock to the rescue: As I said (13)

sean007

07/27/2025 3:47:06 PM

"The Shelf offering"...shows We have a (5)

Mr3Putt

07/27/2025 3:21:58 PM

Upwithstock to the rescue: (13)

USS JOHNSTON

07/27/2025 2:54:06 PM

I'd like to hear from business-savvy (1)

sean007

07/27/2025 2:41:17 PM

I am neither a monitor or a (1)

biloxiblues

07/27/2025 1:17:33 PM

Thank you!

Evil Rabbit

07/27/2025 11:09:09 AM

Based on the correction, I deleted the (3)

biloxiblues

07/27/2025 11:05:41 AM

Sean007 My source is incorrect about (5)

Katangolo

07/27/2025 12:41:42 AM

Love it! Thanks, Brent and keep it (1)

brentie

07/26/2025 11:57:39 PM

Not much to this article but I like (3)

Katangolo

07/26/2025 10:56:08 PM

OK, now were talking. Brentie thanks (2)

Katangolo

07/26/2025 10:52:09 PM

Not a bad idea

sean007

07/26/2025 9:13:11 PM

I danced around the website... put into (3)

Jake2212

07/26/2025 8:16:05 PM

biloxi: So if sean rummaged through the (8)

biloxiblues

07/26/2025 7:48:51 PM

Probably did not want us to (1)

Ramjet

07/26/2025 6:43:03 PM

Yes we are very fortunate to have (1)

sean007

07/26/2025 6:07:53 PM

Looked for any mention of (6)

sean007

07/26/2025 4:29:12 PM

Thanks, Mr. Rabbit...for holding down (3)

sean007

07/26/2025 4:20:07 PM

The Boogeyman language is typical (3)

Emmitt

07/26/2025 4:03:44 PM

I salute our Mods on this board. The (27)

sean007

07/26/2025 3:57:35 PM

Now that was a Dumb Mac...nothing (1)

Ramjet

07/26/2025 2:57:18 PM

Agreed. About the leverage provided by (11)

Evil Rabbit

07/26/2025 2:47:34 PM

I love a good pun. Thanks for the (10)

WhatIf

07/26/2025 2:22:41 PM

If you left that would make you a Hare (6)

biloxiblues

07/26/2025 2:08:10 PM

I had no idea who this clown was, but (10)

Niele

07/26/2025 1:58:59 PM

I know folks here dont care to hear (15)

Evil Rabbit

07/26/2025 1:50:23 PM

Done. It really is unfortunate that (3)

biloxiblues

07/26/2025 1:40:39 PM

I hope a moderator deletes his (1)

Evil Rabbit

07/26/2025 1:36:01 PM

Riz, what is your end game here? What (19)

biloxiblues

07/26/2025 12:29:32 PM

Yes, we just pulled this out of the (2)

brentie

07/26/2025 10:27:24 AM

https://www.tradingview.com/news/tradin (7)

brentie

07/26/2025 10:01:46 AM

From stocktwits... (12)

MIM-104

07/26/2025 7:18:43 AM

T or F ? (2)

Nt2innvovate

07/26/2025 7:09:19 AM

Agree that for a potential partner, (2)

ohm20

07/26/2025 5:04:57 AM

By any chance is the vault mentioned Al (6)

ohm20

07/26/2025 4:55:17 AM

I am asking that if we only have ?150 (12)

ohm20

07/26/2025 4:49:27 AM

I don't understand moving forward with (13)

Newer

Older

Recent Articles

• Implantica's Q3 Report Highlights Progress Towards FDA Approval
• Chevron Prepares to Announce Q3 Financial Results Soon
• Exciting Tesla Cybercab Prototype: Steering Wheel Surfaces
• China Leads the Way in Urban Health amidst Climate Challenges
• Zoomlion's Vision for Sustainable Smart Cities Worldwide
• Crédit Agricole S.A. Completes Share Repurchase Program Successfully
• Fresnillo Makes Strategic Move to Acquire Probe Gold
• Projected Growth of Genomics Data Analysis Market to 2034
• Nanobiotix Secures Up to $71 Million in Innovative Funding
• Exciting Launch of $PRDT Token Promises Revenue Sharing Rewards
• Michael Burry's Caution: Avoiding Market Bubbles in 2025
• Rep. Marjorie Taylor Greene Increases Investment in Tech Stocks
• AB Artea Bankas Receives Updated Capital Requirements from ECB
• Mohamed El-Erian Analyzes AI Market: Cautiously Optimistic
• Bekaert's Share Buyback Program and Liquidity Actions Explained
• Sidetrade Partners with NX to Enhance CFO Agility and Growth
• Top Stock Performers: Insights on Major Market Movers
• Facephi Shows Strong Financial Performance and Future Growth
• Kalmar Reports Strong Q3 2025: Profitability and Success in Services
• Loomis Achieves Remarkable Performance in Recent Quarter
• Analyzing Investor Sentiment: Nasdaq's Recent Performance Trends
• Exxon Mobil's Q3 Earnings Preview: Analyst Predictions and Insights
• DXS International's Annual Report: Key Insights and Financials
• Digitalist Group's Third Quarter Review Highlights 2025 Results
• Strong Q3 Results Highlight Growth and Stability for WEHB
• NB Private Equity Partners Effectively Executes Share Buyback
• ICG Enterprise Trust plc Makes Strategic Share Buyback Move
• Understanding the Voting Rights of Northern Venture Trust PLC
• Nanobiotix Partners with Healthcare Royalty for $71 Million Deal
• Fresnillo Enters Agreement to Purchase Probe Gold for C$780M
• Understanding Voting Rights at Northern 2 VCT PLC
• Notable Growth for INVL Technology in 2025 Financials
• Understanding the Latest Net Asset Value of INVL Technology
• Nxera Pharma's Vision Unveiled at Upcoming London Healthcare Conference
• Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
• Tetragon Financial Group Reveals September 2025 Insights
• Bioretec Ltd Updates Financial Report Details for 2025
• Loomis Reports Robust Performance in Q3 2025 with Growth
• Investments from Optiver and Qube Strengthen McKay Brothers
• Strategic Investments by Optiver and QRT Propel McKay Brothers
• Mycenax Partners with RIN Institute to Transform ADC Technology
• Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
• Corbus Pharmaceuticals Moves Forward with Public Offering
• S&P 500 Achieves Historic Winning Streak and Market Insights
• Key Challenges Highlighted by Michael Saylor for Growth Strategy
• Ecer.com Launches Innovative AI Marketplace Strategy for Trade
• Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
• DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
• Danske Bank Sees Positive Trends and Growth for 2025
• Sampo plc's Latest Share Buyback Program and Results